Local Complement Contributes to Pathogenic Activation of Lung Endothelial Cells in SARS-CoV-2 Infection-Reference-Cited by-同舟云学术

Local Complement Contributes to Pathogenic Activation of Lung Endothelial Cells in SARS-CoV-2 Infection

Published:2023-08 Issue:2 Volume:69 Page:210-219
ISSN:1044-1549
Container-title:American Journal of Respiratory Cell and Molecular Biology
language:en
Short-container-title:Am J Respir Cell Mol Biol

Author:

Zhang Hui¹,Gerasimovskaya Evgenia¹,McCarthy Mary K.²,May Nicholas A.²,Prasad Ram Raj¹,Riddle Suzette¹,McKeon B. Alexandre¹,Kumar Sushil¹,Li Min¹,Hu Cheng-Jun³,Frid Maria G.¹,Morrison Thomas E.²,Stenmark Kurt R.¹

Affiliation:

1. Cardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Medicine,

2. Department of Immunology and Microbiology, and

3. Department of Craniofacial Biology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado

Funder

National Heart, Lung, and Blood Institute

U.S. Department of Defense

American Lung Association

Children’s Hospital Colorado Research Scholar Award

Publisher

American Thoracic Society

Subject

Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Link

https://www.atsjournals.org/doi/pdf/10.1165/rcmb.2022-0373OC

Reference49 articles.

1. COVID-19: the vasculature unleashed

2. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

3. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

4. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?

5. Severe covid-19 pneumonia: pathogenesis and clinical management

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 Lurking and Lingering in the Depths of Lungs;American Journal of Respiratory and Critical Care Medicine;2024-04-01

2. Emerging role of complement in COVID-19 and other respiratory virus diseases;Cellular and Molecular Life Sciences;2024-02-18

3. Eculizumab suppresses zymosan-induced release of inflammatory cytokines IL-1α, IL-1β, IFN-γ and IL-2 in autologous serum-substituted PBMC cultures: Relevance to cytokine storm in Covid-19;Biomedicine & Pharmacotherapy;2023-10

4. Optimizing the use of vilobelimab for the treatment of COVID-19;Expert Opinion on Biological Therapy;2023-07-10